by Jordana Choucair | Jul 1, 2022 | Life Sciences
Senate Democrats plan to submit a revised proposal to lower prescription drug prices for a key procedural review in the coming days as they press forward with preparations for a vote on Biden’s economic package. The plan would allow Medicare to negotiate lower prices...
by Jordana Choucair | Jul 1, 2022 | Opioid/Substance Use Disorders
New documents published by the University of California at San Francisco and Johns Hopkins University show that McKinsey & Company found opportunities to boost opioid manufacturers’ sales amid the addiction crisis from 2004 to 2019. According to the...
by Jordana Choucair | Jul 1, 2022 | Opioid/Substance Use Disorders
The National Academy of Medicine (NAM) published a recap of a meeting held by two of its workgroups to examine challenges to fully integrating telehealth and virtual care for both pain management and substance use disorder (SUD). The first meeting of the four-part...
by Jordana Choucair | Jul 1, 2022 | Payers
Effective today, the three major U.S. credit reporting companies will stop counting paid medical debt on the reports that banks, potential landlords, and others use to judge creditworthiness. The companies also will start giving people a year to resolve delinquent...
by Jordana Choucair | Jun 30, 2022 | D.C. News
The House Appropriations Committee is scheduled to markup a fiscal 2023 spending bill that would provide $124.2 billion to the U.S. Department of Health and Human Services (HHS), an increase of $15.6 billion above enacted levels. The billion allocates an additional $2...
by Jordana Choucair | Jun 30, 2022 | Inequities and SDOH
A new analysis found that maternal mortality rates rose substantially during the COVID-19 pandemic, with deaths disproportionately impacting Hispanic and Black women. According to the National Center for Health Statistics, maternal mortality rates increased 18.4...
Recent Comments